The current and future burden of hepatitis B in Switzerland: a modelling study

CONCLUSIONS: Thanks to the historical vaccination programmes and the continued rollout of universal 3-dose coverage in the first year of life, Switzerland is expected to exceed the global health sector strategy targets for the reduction of incidence. While overall prevalence is decreasing, the current diagnosis and treatment levels remain below global health sector strategy targets.PMID:37410921 | DOI:10.57187/smw.2023.40086

Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Francesco Negro Beat M üllhaupt David Semela Sarah Blach Philip Bruggmann Andrea De Gottardi Jean-Francois Dufour Montserrat Fraga Antonio Galante Homie Razavi Joana Vieira Barbosa Devin Razavi-Shearer Source Type: research